Lasix 40 mg tablete
| Name | Lasix 40 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-797987648 |
| Active Substance | furosemid |
| Composition | jedna tableta sadrži 40 mg furosemida |
| Pharmaceutical Form | tableta |
| Manufacturer | Opella Healthcare International SAS, Compiegne, Francuska Sanofi S.r.l., Scoppito (L'Aquila), Italija |
| Marketing Authorisation Holder | Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
| Marketing Authorisation Date | 01.09.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/537 |
| Registration Number | 381-12-01/70-23-25 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C03CA01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
